Dynamic Contrast Enhanced MRI

Dynamic contrast enhanced (DCE) MRI is the foundation of clinical breast MRI. Contrast is currently required for breast cancer detection; non-contrast methods remain investigational.

Mechanism

During DCE MRI, the uptake and washout of a gadolinium contrast agent is observed over time using pre- and post-contrast imaging series. Breast cancers are characterized by abnormal, highly permeable neovascularity and typically enhance rapidly — within the first 60–120 seconds after contrast administration.

Key Technical Requirements

  • Field strength: 1.5T or higher required for sufficient spatial resolution
  • Coil: Dedicated bilateral breast coil; simultaneous bilateral acquisition
  • Contrast: Gadolinium, weight-based dose
  • Fat removal: Active fat suppression of acquired DCE sequences and/or subtracted (pre-minus-post) images; both methods are acceptable and often combined
  • Early post-contrast series: Acquired at approximately 60–120 seconds after contrast injection — the time window when most breast cancers demonstrate peak enhancement

Timing Terminology (v2025 Update)

The previously used term “initial” post-contrast series is replaced by “early” post-contrast series in v2025, defined as the series obtained at approximately 60–120 seconds after contrast.

Fat Removal: Subtraction Pitfall

Subtraction images (pre-minus-post) are generated from images that may not be perfectly coregistered. This can produce artifactual “pseudoenhancement” — radiologists should be alert to this when assessing BPE or subtle lesion enhancement on subtracted images.

Reporting Requirements

Reports should describe:

  • Field strength and pulse sequences
  • Gadolinium dose and type
  • Contrast injection details
  • Timing of key post-contrast series (especially the early post-contrast)
  • Number and length of post-contrast sequences
  • Computer-aided evaluation if used
  • Significant artifacts (motion, susceptibility, fat suppression failure, kinetics artifacts)

Enhancement Kinetics

Kinetics describe the temporal behavior of contrast enhancement:

PhaseCategories
Early phaseSlow / Medium / Fast
Delayed phasePersistent / Plateau / Washout

Kinetics are most useful when morphology is not definitively benign or suspicious. Morphology (shape, margin, internal enhancement pattern) remains the primary assessment tool.

Board Pearl

The early post-contrast series at 60–120 seconds is the single most important series for breast cancer detection. Protocol standardization of this timing is critical for consistent comparison over time.